hims hers compounded semaglutide The FDA announced plans to take action against non-FDA-approved GLP-1 receptor agonists, a move that prompted telehealth company & to yank its new (Wegovy) weight-loss pill from the FDA Blocks Hims & Hers

GLP-1 acts on the brain to induce feelings of satiety, thus reducing appetite and leading to weight loss

Tirzepatide Combined With Cognitive-Behavioural Therapy (CBT) for Adults With Alcohol Use Disorder (AUD) and Overweight/?Obesity (OOB) ID NCT07292519

Regular consultations with your healthcare provider can help tailor the treatment to your specific needs and circumstances

$15M raised, plus one $100M acquisition offer we turned down to keep building

Speak with your prescriber to review pace of weight loss, nutrition, and overall health

and (3) completing a set of tests for pharmaceutical quality assessment, including examining logistics, visual package inspection, microbiological contamination, and chemical analysis of purchased products (Figure 1)